Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.
Robitussin Dry Cough Medicine.
Pharmaceutical Form |
---|
Bright pink clear liquid for oral administration. |
Active Ingredient: Dextromethorphan Hydrobromide Ph Eur 7.5mg per 5ml.
Excipients with known effect:
Amaranth (E123) - 0.33 mg of Amaranth in each 10 ml dose.
Ethanol: 219.3 mg of alcohol (ethanol) in each 10 ml dose.
Maltitol (E965): 484 mg of Maltitol in each 10 ml dose.
Sodium: 21.94 mg of Sodium in each 10 ml dose.
Sodium benzoate (E211): 12.0 mg of Sodium Benzoate in each 10 ml dose.
Sorbitol (E420): 2094 mg sorbitol in each 10 ml dose.
For full list of excipients see section 6.1
Active Ingredient | Description | |
---|---|---|
Demorphan |
Dextromethorphan is a non-opioid antitussive drug. The major metabolite of dextromethorphan, dextrorphan, binds with high affinity to σ-receptors to produce its antitussive activity without exhibiting the classic opiate effects that occur from binding into μ- and δ-receptors. In larger than therapeutic doses, dextrorphan is also an antagonist of N-methyl-D-aspartate (NMDA) receptors. |
List of Excipients |
---|
Glycerol |
PET bottles containing 100ml or 250ml with PET lined PP/HDPE screw caps.
A clear polypropylene measuring cap also included.
GlaxoSmithKline Consumer Healthcare (UK) Trading Limited, Brentford, TW8 9GS, U.K.
PL 44673/0207
01 September 1993
Drug | Countries | |
---|---|---|
ROBITUSSIN DRY COUGH | Ireland, New Zealand, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.